Abdominal Sacral Colpopexy in Patients with Gynecologic Cancer: Report of 25 Cases with Long-Term Follow-Up and Literature Review

By Patsner B.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 504-508

Elsevier

Access to resources Recommend Favorite

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study

By Thigpen J.T.   Blessing J.A.   Olt G.   Lentz S.S.   Bell J.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 581-586

Elsevier

Access to resources Recommend Favorite

Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer

By Gropp M.   Meier W.   Hepp H.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 94-98

Elsevier

Access to resources Recommend Favorite

Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex ( R)) in advanced colorectal cancer

By Farrugia D.C.   Norman A.R.   Cunningham D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 987-991

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of women with ovarian cancer after positive second-look laparotomy

By Dowdy S.C.   Constantinou C.L.   Hartmann L.C.   Keeney G.L.   Suman V.J.   Hillman D.W.   Podratz K.C.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 563-568

Elsevier

Access to resources Recommend Favorite